Media thread, page-378

I agree with a lot of what you've said but really when you dont have sales or partnerships in place it is hard to push big investors to buy your story. They have managed to get the company into a fantastic position with under 200 million shares issued, not only no debt but also money in the bank. All the while getting products approved. How many bio companies on the asx that also have great products are languishing in no mans land still trying to get approvals with trial after trial.

John Van Der Wielen is the man we have been waiting for. He has already stated the share registry is weak and we need some solid big investors to sure things up and also protect the company from takeover situations. So it seem management are aware of our concerns. I think its going to go up and fast in the next few years.